Letter: faecal microbiota transplantation for irritable bowel syndrome-which improvements are required? Authors' reply
Aliment Pharmacol Ther
.
2020 Dec;52(11-12):1754-1755.
doi: 10.1111/apt.16122.
Authors
Lahtinen Perttu
1
2
,
Jalanka Jonna
3
,
Hartikainen Anna
3
,
Mattila Eero
4
,
Hillilä Markku
2
5
,
Punkkinen Jari
6
,
Koskenpato Jari
7
,
Anttila Veli-Jukka
2
4
,
Tillonen Jyrki
1
,
Satokari Reetta
3
,
Arkkila Perttu
2
8
Affiliations
1
Department of Gastroenterology, Päijät-Häme Central Hospital, Lahti, Finland.
2
Faculty of Medicine, University of Helsinki, Helsinki, Finland.
3
Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
4
Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.
5
Department of Gastroenterology, Helsinki University Hospital, Espoo, Espoo Finland.
6
Department of Gastroenterology, Porvoo Hospital, Porvoo, Finland.
7
Department of Gastroenterology, Aava Medical Centre, Helsinki, Finland.
8
Department of Gastroenterology, Helsinki University Hospital, Helsinki, Finland.
PMID:
33205871
DOI:
10.1111/apt.16122
No abstract available
Publication types
Comment
MeSH terms
Fecal Microbiota Transplantation*
Feces
Humans
Irritable Bowel Syndrome* / therapy